Monthly pegloticase vs placebo
Total adverse events · participants with tophi in gout
Monthly pegloticase showed no clear difference in total adverse events compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.05 [0.98, 1.14]1 study · 127 participantsModerate